Natus Medical Inc  

(Public, NASDAQ:BABY)   Watch this stock  
Find more results for BABY
34.09
+0.10 (0.29%)
After Hours: 34.09 0.00 (0.00%)
Feb 11, 4:35PM EST  
NASDAQ real-time data - Disclaimer
Currency in USD
Range 33.00 - 35.29
52 week 29.34 - 51.05
Open 33.49
Vol / Avg. 165,719.00/358,541.00
Mkt cap 1.12B
P/E 29.85
Div/yield     -
EPS 1.14
Shares 32.96M
Beta 1.05
Inst. own 98%
Apr 20, 2016
Q1 2016 Natus Medical Inc Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
Jan 27, 2016
Q4 2015 Natus Medical Inc Earnings Call - Webcast
Jan 27, 2016
Q4 2015 Natus Medical Inc Earnings Release
Jan 14, 2016
Natus Medical Inc at JPMorgan Healthcare Conference
Dec 1, 2015
Natus Medical Inc at Piper Jaffray Healthcare Conference - Webcast
Nov 19, 2015
Natus Medical Inc at Jefferies Autumn Global Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '15) 2015
Net profit margin 8.55% 10.09%
Operating margin 10.05% 14.23%
EBITD margin - 17.53%
Return on average assets 7.22% 8.29%
Return on average equity 8.88% 10.20%
Employees 948 -
CDP Score - -

Address

6701 Koll Center Pkwy Ste 120
PLEASANTON, CA 94566-8061
United States - Map
+1-925-2236700 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Natus Medical Incorporated (Natus) is a provider of newborn care and neurology healthcare products and services used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and balance and mobility disorders. The Company offers two product families: Neurology, which includes products and services for diagnostic electroencephalography and long term monitoring, intensive care unit monitoring, electromyography, sleep analysis, intra-operative monitoring, and diagnostic and monitoring transcranial doppler ultrasound technology; and Newborn Care, which includes products and services for newborn care, including hearing screening, brain injury, thermoregulation, jaundice management and various disposable products, as well as products for diagnostic hearing assessment for children through adult populations, and others.

Officers and directors

Robert A. Gunst Independent Chairman of the Board
Age: 67
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
James B. Hawkins President, Chief Executive Officer, Director
Age: 59
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Jonathan A. Kennedy Chief Financial Officer, Senior Vice President
Age: 44
Bio & Compensation  - Reuters
Austin F. Noll III Vice President and General Manager - Neurology Strategic Business Unit
Age: 48
Bio & Compensation  - Reuters
Kenneth M. Traverso Vice President, General Manager - Newborn Care Strategic Business Unit
Age: 54
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Ajay A. Bhave Vice President - Global Engineering
Age: 58
Bio & Compensation  - Reuters
D. Christopher Chung M.D. Vice President - Medical Affairs, Quality & Regulatory
Age: 51
Bio & Compensation  - Reuters
Doris E. Engibous Independent Director
Age: 60
Bio & Compensation  - Reuters
Kenneth E. Ludlum Independent Director
Age: 61
Bio & Compensation  - Reuters
Will M. Moore Jr. Independent Director
Age: 66
Bio & Compensation  - Reuters